Jennifer Amengual – New Associate Editor for Blood Neoplasia!
Blood Journals Portfolio shared on LinkedIn:
”We are delighted to introduce Dr. Jennifer Amengual, new Associate Editor for Blood Neoplasia!
Dr. Amengual is an Associate Professor of Medicine at Columbia University Irving Medical Center and a physician-scientist whose research focuses on developing targeted therapies for patients with lymphoma.
Her work has advanced our understanding of epigenetic and transcriptional pathways in germinal center–derived B-cell and T-cell lymphomas, as well as strategies to predict, prevent, and treat post-transplant lymphoproliferative disorders.
Beyond her research, Dr. Amengual is a dedicated mentor and an active member of American Society of Hematology, contributing to programs such as CRTI, TRTH, and the Hematology Review Series.
She has also led impactful clinical trials through ETCTN/CTEP, SWOG, and investigator-initiated studies.
Please join us in welcoming Dr. Amengual to the Blood Neoplasia team.”
Stay updated with Hemostasis Today.
-
Jul 15, 2026, 07:15Sandrine Horman: Back From an Inspiring Week at ISTH 2026
-
Jul 15, 2026, 06:55Christopher Devany: Great to Be Here in Paris for the ISTH 2026
-
Jul 15, 2026, 06:45Viviana Di Fabio: The Synergy Between Hematology and Hemostasis Starts with Platelets
-
Jul 15, 2026, 06:35Wolfgang Miesbach: Paediatric Phase 3 BASIS KIDS Data for Marstacimab at ISTH 2026
-
Jul 15, 2026, 06:06Marija Tashkovska: Advancing Knowledge and Clinical Practice Through ISTH 2026
-
Jul 15, 2026, 05:55Hong Chow: Where Science Meets Art at ISTH 2026
-
Jul 15, 2026, 05:47Maria Magnusson: Advancing Hemostasis and Thrombosis Through Science and Collaboration at ISTH 2026
-
Jul 15, 2026, 05:32Alessandro Ciarcia: Connecting Expertise and Innovation to Transform the Future of TTP Management at ISTH 2026
-
Jul 15, 2026, 05:02Louise St. Germain Bannon: Scientific Collaboration at ISTH 2026